Company profile: Title21
1.1 - Company Overview
Company description
- Provider of fully integrated, flexible software for health science organizations to increase operational efficiency, close compliance gaps, and improve patient care. Products include cellular therapy and BMT data management platforms; quality management (document control, CAPA, audit, training); audit management; equipment management for preventive maintenance and calibration; and web-based CAPA software.
Products and services
- Title21 Quality Management Software: compliance-focused software supporting document control, CAPA, audit, and training to increase operational efficiency and improve patient care and outcomes for health science organizations
- Title21 Cellular Therapy Solution: integrated platform managing data and workflows in cell therapy labs, ensuring compliance and traceability to increase operational efficiency and improve patient care and outcomes
- Title21 BMT Software: comprehensive data management platform for blood and marrow transplant programs, streamlining clinical and laboratory operations to increase operational efficiency and improve patient care and outcomes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Title21
Deep 6 AI
HQ: United States
Website
- Description: Provider of an AI-powered clinical research platform that mines EMR data and analyzes structured data (e.g., ICD-10 codes) and unstructured clinical data (doctor's notes, pathology reports, operating notes) to match patients to trials, accelerate recruitment, assess trial feasibility and optimize study design, select sites, monitor enrollment in real time with physician workflow integration, and deliver post-study performance insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep 6 AI company profile →
NextBio
HQ: United States
Website
- Description: Provider of an ontology-based software platform enabling life science researchers to search, discover, and share knowledge across public and proprietary data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NextBio company profile →
Scientist.com
HQ: United States
Website
- Description: Provider of AI-powered public and private marketplaces that connect buyers and sellers of scientific research services for outsourced R&D, simplifying sourcing and reducing time, cost and risk. Solutions include AI-driven procurement with instant quotes and supplier comparisons, 24/7 Research Concierge, COMPLi for secure sourcing of regulated services, enterprise tools from CROs, a supplier platform, and VERIF.i for transparency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scientist.com company profile →
OmniComm
HQ: United States
Website
- Description: Provider of Electronic Data Capture and eClinical technologies for clinical trial organizations and the life sciences industry, including pharma, biotech, CROs, diagnostic and device firms, and academic medical centers. Offerings include TrialMaster EDC; CTMS Master; RTSM Master; eTMF Master; AnjuEPS eSource/site automation for Early Phase clinics; and TA Scan clinical intelligence for study planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniComm company profile →
Within3
HQ: United States
Website
- Description: Provider of a SaaS virtual engagement and digital collaboration platform for life science companies to compliantly connect and engage physicians, nurses, payers, and patients in groups large or small; offerings include an Insights Management Platform, AI-powered virtual engagement applications for global stakeholder discussions, client success support, and data science services for disease community analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Within3 company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Title21
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Title21
2.2 - Growth funds investing in similar companies to Title21
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Title21
4.2 - Public trading comparable groups for Title21
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →